Product Program year 2023 Source: CMS Open Payments

Anavip

Biological Antivenin

Open in the dashboard

General payments

$1,740

84 payments

Research payments

$0

0 payments

Through program year 2023, $1,740 in general payments and $0 in research payments were reported against Anavip (Antivenin).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2023 General $1,433 72
2021 General $17 1
2020 General $290 11

Breakdown

Who paid General payments · program years 2020–2023
  1. Rare Disease Therapeutics, Inc. $1,740 84 payments
Top recipients General payments · program year 2023
  1. Bryan Wilson Pediatric Emergency Medicine · Aurora, CO $169 12% · 1 payment
  2. Richard Dart Medical Toxicology · Aurora, CO $98 7% · 1 payment
  3. Miguel Fernandez Emergency Medicine · San Antonio, TX $38 3% · 1 payment
  4. Nicholas Petrus Physician Assistant · Laurens, SC $33 2% · 1 payment
  5. Meagan Spear Emergency Medicine · Gulfport, MS $33 2% · 1 payment

The top 5 of 72 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Emergency Medicine $517 36% · 31 practitioners
  2. Physician Assistant $225 16% · 14 practitioners
  3. Pediatric Emergency Medicine Pediatrics $169 12% · 1 practitioner
  4. Medical Toxicology Emergency Medicine $126 9% · 2 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $106 7% · 6 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Colorado $295 21% · 3 recipients
  2. North Carolina $202 14% · 12 recipients
  3. Mississippi $185 13% · 9 recipients
  4. South Carolina $114 8% · 6 recipients
  5. Georgia $98 7% · 8 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

84 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record